Literature DB >> 12376168

Increase in testosterone metabolism in the rat central nervous system by formalin-induced tonic pain.

Hossein Amini1, Abolhassan Ahmadiani.   

Abstract

The effects of formalin-induced tonic pain (FITP) on testosterone (T) concentrations in the central nervous system (CNS) and serum were investigated in rats. T was nearly eliminated from the brain and spinal cord 1.5 and 24 h after a single subcutaneous injection (100 microl/rat, sc) of 5% formalin and its levels were similar to that seen following castration. In serum, T concentrations were decreased significantly 1.5 h following formalin injection, but after 24 h, the serum level of T was within normal range. T concentrations in the brain, spinal cord, and serum were not modified 20 min after formalin injection. Pretreatment of rats with finasteride, a 5alpha-reductase (5alpha-R) inhibitor (5 mg/kg, sc) blocked T elimination from the brain and spinal cord by FITP, but it failed to prevent decrease in serum T. However, 3 h after administration of exogenous T (5 mg/kg, sc), FITP did not cause a significant decrease in T levels in the CNS and serum. These results suggest that FITP eliminates endogenous T in the brain and spinal cord by increasing 5alpha-R activity in the CNS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376168     DOI: 10.1016/s0091-3057(02)00986-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Central 5-alpha reduction of testosterone is required for testosterone's inhibition of the hypothalamo-pituitary-adrenal axis response to restraint stress in adult male rats.

Authors:  Robert J Handa; Andrea E Kudwa; Nina C Donner; Robert F McGivern; Roger Brown
Journal:  Brain Res       Date:  2013-07-21       Impact factor: 3.252

2.  Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats.

Authors:  Anna Maria Aloisi; Ilaria Ceccarelli; Paolo Fiorenzani; Melinda Maddalena; Alessandra Rossi; Valentina Tomei; Giuseppina Sorda; Barbara Danielli; Michele Rovini; Andrea Cappelli; Maurizio Anzini; Antonio Giordano
Journal:  Mol Pain       Date:  2010-10-26       Impact factor: 3.395

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.